Vertex Pharmaceuticals Inc. Q3 Profit Advances

Vertex Pharmaceuticals Inc. (VRTX) announced earnings for its third quarter that increased from last year

The company's bottom line came in at $0.93 billion, or $3.59 per share. This compares with $0.85 billion, or $3.28 per share, in last year's third quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.04 billion or $4.01 per share for the period.

The company's revenue for the quarter rose 17.7% to $2.33 billion from $1.98 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :

-Earnings (Q3): $0.93 Bln. vs. $0.85 Bln. last year.
-EPS (Q3): $3.59 vs. $3.28 last year.
-Revenue (Q3): $2.33 Bln vs. $1.98 Bln last year.

Full year revenue guidance: $8.8 to $8.9 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT